Recently published papers: A series of negative results by Galloway, Robert & Venn, Richard
Available online http://ccforum.com/content/13/1/119
Page 1 of 3
(page number not for citation purposes)
Abstract
Studies with negative results rarely hit the headlines. But the
results are often just as important as the positive ones. A number
of ‘negative headline’ studies are looked at in this review: intensive
insulin therapy regime, thrombolysis in cardiac arrest, the effects of
nutritional guidelines and rapid response outreach teams.
Intensive insulin therapy
The debate about intensive insulin therapy continues to be
fought, with a recent paper from Saudi Arabia by Arabi and
colleagues [1].
In 2001, a landmark paper by van de Berghe and colleagues
[2] showed that an intensive insulin regime resulted in a
significantly lowered mortality in a surgical intensive care unit
(ICU) compared to standard insulin therapy. As intensive
insulin therapy is a relatively simple intervention with a
promising survival benefit, it is no wonder it was widely
adopted by ICUs around the world. However, a more
cautious attitude has recently been adopted following the
negative results of a follow-up study by van de Berghe in the
medical ICU [3] and the results from the VISEP study [4]
suggesting harm from tight glycaemic control.
In Arabi’s mixed medical and surgical ICU single-centred
study, 623 patients were randomly allocated to either inten-
sive insulin therapy (aiming to keep glucose levels between
4.0 and 6.1 mmol/L) or conventional insulin therapy (between
10.0 and 11.1 mmol/L). The primary end point of ICU
mortality was used. A plethora of secondary end points were
assessed, including rates of hypoglycaemia.
Results showed there was no statistical difference in ICU
mortality between the two groups (13.5% versus 17.1%).
There was also no difference in any of the secondary end
points except hypoglycaemia, which occurred more fre-
quently in the intensive insulin therapy arm. Based on these
results, the authors stated that they ‘do not advocate
universal application of intensive insulin therapy to ICU
patients’.
The study was powered for an absolute reduction of 8%
based on extrapolating the results from van de Berghe and
colleagues’ study [1], which showed an absolute mortality
reduction of 3.4%. Therefore, it may be criticised that this
was an underpowered study; the trend was to a reduction in
mortality - a non-significant absolute risk reduction of 3.6%.
To look for a small absolute reduction of mortality a large trial
is needed. Currently, such a randomized, multicentered trial is
being conducted. Aptly named NICE-SUGAR [5], it com-
pleted the last of the recruitment in November 2008 and
results are now awaited.
More evidence that tight glucose control may not be
beneficial for all patients came from a paper by Oddo and
colleagues [6]. They performed a retrospective analysis of
data from 20 patients with severe brain injury. As part of an
observational study, these patients received intensive insulin
therapy to try and keep their systemic glucose levels between
4.4 and 6.7 mmol/L.
Brain tissue markers of glucose metabolism were obtained by
a frontal lobe microdialysis catheter. Cerebral glucose levels
were measured as were lactate and pyruvate levels. A brain
energy crisis was defined as a cerebral microdialysis glucose
of <0.7 mmol/l with a lactate/pyruvate ratio >40.
Systemic blood samples were categorised as low sugar
(<4.4 mmol/L), tight (4.4 to 6.7 mmol/L), intermediate (6.8 to
10.0 mmol/L) and high (>10 mmol/L). Compared to inter-
mediate control, tight glycaemia control was associated with
a greater prevalence of low cerebral microdialysis glucose
levels and more brain energy crises. The number of brain
energy crises was also associated with an increased risk of
hospital death.
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Although this is only a small study - it too leaves us with
difficult questions. It is well accepted that hyperglycaemia
should be controlled after head injury - but clearly we need to
be careful because tight control may cause harm.
Cardiac arrest management
Meanwhile, the search for improvement in survival from out of
hospital cardiac arrest continues. Approximately 70% of
patients with cardiac arrest have underlying acute myocardial
infarction or pulmonary embolism. Therefore, there could be a
role for routine use of thrombolysis during CPR.
A pan-European study [7] investigated this. Patients who had
a presumed cardiac related cardiac arrest were randomised
in the pre-hospital setting to either tenecteplase or placebo. If
the patient was in asystole or PEA (pulseless electrical
activity), the drug was given immediately. If in a shockable
rhythm, then it was given after the third shock if there had
been no return of spontaneous circulation. The primary end
point was 30 day survival. Unfortunately, the results showed
no improvement in survival or in any of the secondary
outcomes. Although this study shows that there is no
evidence for routine use of thrombolysis in cardiac arrest, the
authors make it clear that the results do not suggest that
thrombolysis should be withheld in patients in whom the
primary pathological condition is known to be responsive.
Indeed, patients who were presumed to have a pulmonary
embolus were excluded from the randomisation and given
tenecteplase.
Nutrition on ICU
There is evidence that providing early nutritional support to
ICU patients reduces mortality. However, this is not
universally followed. Doig and colleagues [8] presented a
clustered randomised controlled trial across 27 ICUs in
Australia and New Zealand to see if evidence-based feeding
guidelines could be implemented and reduce mortality. Half
the participating ICUs carried on their normal feeding policy
whilst the other half implemented evidence-based guidelines
with specific measures aimed at improving compliance with
the guidelines. A practice-change strategy of 18 specific
interventions was devised. Individual hospitals used various
aspects of this strategy.
The results of the study show that although guideline ICUs
fed patients earlier and achieved calorific goals more often,
there was no significant difference in mortality, ICU length of
stay or hospital length of stay. This surprising and somewhat
disappointing result needs explanation. It could be that
original research from which the guidelines were taken either
overestimated the benefit of early feeding or was not
transferable to this patient setting.
Other explanations may be that compliance with the
guidelines was not 100% or the ‘Hawthorne’ effect of the
control group. Knowing that they were being studied may
have led to improvements in their nutrition management regard-
less of guidelines. But the important take home message is
that implementing nutrition clinical care guidelines improves
feeding regimes.
Rapid response teams
Although it seems rational to have outreach teams that
respond to a set of deranged physiological parameters, few
studies have showed evidence for their benefit and others
show no benefit [9]. Another negative trial is from Kansas,
Missouri [10]. A prospective cohort study looked at over
24,000 adult inpatients admitted for 20 months before and
after a rapid response team was introduced. The general
trends in the first 20 months (that is, the decreasing number
of cardiac arrest calls) were taken into consideration in the
statistical analysis.
Although there was a reduction in the number of out of ICU
cardiac arrests, this did not translate into a significant
difference in hospital mortality. It may be that introducing a
rapid response team allows a more dignified death in those
whose resuscitation is futile and, therefore, reduces the
number of cardiac arrest calls without improving mortality. On
the other hand, mortality may not have been affected because
the interventions were ineffective. This needs further study.
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